RECORDING
SLIDES
This presentation will provide a background in how cannabis products have evolved in the wake of legalization in many U.S. states, including descriptions of different modes of use, changing THC content, and market trends. The problem of unregulated hemp-derived products, such as Δ8-THC, will be touched on. The presenter will describe how cannabis use impacts physical and mental health, who is at greatest risk of harm, and how policy changes and consumer education could help reduce risks.
OBJECTIVES
- At the end of the presentation, attendees will be able to:
recognize at least 3 types of cannabis products available in legal adult consumer markets in the U.S. - describe three ways in which cannabis use affects health
- discuss different cannabis policies that could reduce harm from use
- describe at least 2 things to consider when designing consumer education campaigns
FACILITATOR
Sharon Garrett, MPH, MA is a Research Scientist at the University of Washington’s Addictions, Drug & Alcohol Institute (ADAI). Since 2012, she has been an active member of ADAI’s Cannabis Education & Research Program (CERP), where she has collaborated on various projects exploring public health impacts of cannabis legalization in WA State. She has contributed to projects funded by the WA State I-502 dedicated marijuana fund to better understand adult cannabis use in the context of legalization, including focus groups with adult cannabis users, cannabis retail store staff, and parents who use cannabis. In 2022, this team evaluated policy options for reducing harms related to high-THC products.